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Gene activation-associated long noncoding RNAs function in
mouse preimplantation development
Nobuhiko Hamazaki1,2, Masahiro Uesaka1,2, Kinichi Nakashima2, Kiyokazu Agata1 and Takuya Imamura1,2,*
ABSTRACT
In mice, zygotic activation occurs for awide variety of genes, mainly at
the 2-cell stage. Long noncoding RNAs (lncRNAs) are increasingly
being recognized as modulators of gene expression. In this study,
directional RNA-seq of MII oocytes and 2-cell embryos identified
more than 1000 divergently transcribed lncRNA/mRNA gene pairs.
Expression of these bidirectional promoter-associated noncoding
RNAs (pancRNAs) was strongly associated with the upregulation of
their cognate genes. Conversely, knockdown of three abundant
pancRNAs led to reduced mRNA expression, accompanied by
sustained DNA methylation even in the presence of enzymes
responsible for DNA demethylation. In particular, microinjection of
siRNA against the abundant pancRNA partner of interleukin 17d
(Il17d) mRNA at the 1-cell stage caused embryonic lethality, which
was rescued by supplying IL17D protein in vitro at the 4-cell stage.
Thus, this novel class of lncRNAs can modulate the transcription
machinery in cis to activate zygotic genes and is important for
preimplantation development.
KEY WORDS: Long noncoding RNA, DNA demethylation, Early
mouse preimplantation development, Zygotic gene activation,
Epigenetic regulation, Pluripotency
INTRODUCTION
Transcription of the zygote genome begins mainly at the 2-cell
stage. Genome-wide gene activation in the zygote, termed zygotic
gene activation (ZGA), is regarded as crucial for embryos to
acquire the potency to form all cell types. In the mouse, ZGA
starts around the pronuclear stage, followed by a major wave of
transcription at the 2-cell stage (Aoki et al., 1997; Latham et al.,
1991). During ZGA, the patterns of various types of DNA
and histone modification are dynamically reconstructed. For
example, the sperm genome is tightly packaged by protamines that
suppress nascent transcription (Braun, 2001). These sperm-
derived protamines are replaced with maternally hyperacetylated
histones that allow the onset of nascent transcription in the zygote
(Santos et al., 2005). DNA demethylation is another well-known
epigenetic event involved in the reconstruction of zygote
chromatin structure. It has long been believed that after
fertilization the bulk of the DNA, including repeat sequences
such as long interspersed nuclear elements (LINEs), becomes
demethylated as a major part of epigenetic reprogramming
(Farthing et al., 2008; Mayer et al., 2000; Oswald et al., 2000).
In actuality, DNA methylation at individual promoter regions
differs during the epigenetic reprogramming (Borgel et al., 2010;
Smallwood et al., 2011; Smith et al., 2012). The DNA
methylation pattern of promoter regions seems to be determined
in a gene-specific manner by an equilibrium between DNA
methylation and demethylation. Thus, distinct and sequence-
specific machineries should regulate this limited program of gene
activation. One key issue is how such sequence-specific gene
activation is achieved towards the acquisition of pluripotency in
early mouse embryos.
Long noncoding RNAs (lncRNAs) constitute one group of
factors that can explain such local epigenetic alterations. The
number of known lncRNAs is now rapidly increasing, and
experimental evidence for epigenetic alterations mediated by long
intergenic noncoding RNAs, a fraction of lncRNAs, is
accumulating. For example, HOTAIR acts as a chromatin repressor
at hundreds of promoters with polycomb repressive complex 2
(Gupta et al., 2010; Rinn et al., 2007; Tsai et al., 2010). Another set
of lncRNAs transcribed from bidirectional promoters, named
promoter-associated noncoding RNAs (pancRNAs), are poly(A)+
RNAs involved in the sequence-specific upregulation of their
oppositely transcribed partner genes (Imamura et al., 2004b;
Tomikawa et al., 2011). Some of these poly(A)+ RNAs have been
confirmed to induce DNA demethylation in their promoter regions
in a sequence-specific manner (Tomikawa et al., 2011). We and
another group have also reported that thousands of pancRNAs are
generated by transcription of the antisense strand and exhibit
expression changes coordinated with their cognate gene. Moreover,
pancRNA possesses the potential to enhance partner gene
expression in a tissue-specific manner in mouse and chimpanzee
brain and heart (Uesaka et al., 2014) and during embryonic stem cell
(ESC) differentiation (Sigova et al., 2013).
Now, the directional RNA-seq technique has become powerful
enough to be applied to very early stage embryos to see whether
RNA-directed gene activation occurs in a significant fraction of
genes, not only for cell differentiation but also for the acquisition of
pluripotency. Therefore, we have started to analyze such
comprehensive data to test the idea that the onset of pancRNA
expression at ZGA can also activate partner gene expression in a
gene-specific manner. In this study, to identify divergently
transcribed pancRNA/gene pairs, we obtained the transcriptome
of mouse oocytes and showed that more than 1000 such pairs are
expressed at ZGA. By manipulating the abundant transcriptional
machineries that involve pancRNA, we showed that pancRNAs are
functionally associated with the activation of their partner genes.
One such pancRNA for the expression of Il17d, a member of the
interleukin gene family, was shown to be indispensable for
embryonic development.Received 24 August 2014; Accepted 5 January 2015
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The identification of more than 1000 antisense pancRNAs in
mouse preimplantation embryos
To examine whether pancRNAs are induced after fertilization, we
generated a total of 111 million directional RNA-seq reads using an
Illumina HiSeq2000 from mouse metaphase II (MII) oocytes and
420 million directional RNA-seq reads from 2-cell embryos (see
Materials and Methods). These reads were mapped to the mouse
mm10 genome. Our RNA-seq data showed robust reproducibility
among biological replicates (Pearson correlation coefficient,
r>0.99; supplementary material Fig. S1). 5′-3′ mapping bias was
comparable to that of RNA-seq data for oocytes in previous studies
(Park et al., 2013) (supplementary material Fig. S2). In order to
verify the strandedness of our directional RNA-seq data, we mapped
the reads to known RefSeq genes and calculated the proportion that
mapped on the correct strand. The results showed that 99.1% of the
reads from MII oocytes and 96.9% of the reads from the fertilized
2-cell embryos mapped on the correct strand. Using our high-
resolution datasets, we identified 618 and 1129 candidate
pancRNAs in MII oocytes and 2-cell embryos, respectively
(Fig. 1A).
Characterization of pancRNA-partnered genes
To test the hypothesis that pancRNAs contribute to the upregulation
of their partner genes during ZGA, we examined the expression
pattern of the pancRNAs and their mRNAs. We found that 836 of
the 1129 pancRNAs were co-expressed with the corresponding
mRNAs in 2-cell embryos (Fig. 1B). We further investigated
Fig. 1. Characterization of pancRNAs by directional RNA-seq. (A) Screening of pancRNA datasets. One hundred oocytes or 2-cell embryos were used for
each analysis, and four replicates were made for the statistical tests. (B) Numbers of pancRNA and mRNA species present in 2-cell embryos. (C) Violin plot of
mRNA levels of 2-cell embryo genes with and without pancRNAs. Groups A, B and C comprise mRNAs without pancRNAs (11658), with the 100 most weakly
expressed pancRNAs, and with the 100 most strongly expressed pancRNAs, respectively. Violin width and white circles indicate gene density and median
expression levels of mRNAs, respectively. Box plots were merged and are indicated by black bars. ***P<0.001. (D) Expression difference of the pancRNA
partners of the upregulated genes and their probability visualized as a density plot. Twofold upregulated genes (which correspond to 520 of the 836 genes in B)
were selected. Below the density plot is a unidimensional plot of the expression difference of each pancRNA (circles), in which density is expressed by color
intensity. (E) A frequently observed sequence motif in the promoter regions of pancRNA-partnered genes. (F) The frequency of the sequence motif in various
gene regions. Sequences with 90% or greater identity to the position weight matrix (pwm) of the motif shown in E were categorized according to their presence on
the sense or antisense strand of the promoter (−500 to −1 bp) and gene body (+1 to +500 bp) regions. The TSSs of the pancRNA-partnered genes provide the
switching points for the observed asymmetric distribution of the CT-rich sequence.
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whether the pancRNA/mRNA pairs exhibit coordinated changes of
expression, and found that most of the upregulated pancRNA/
mRNA pairs showed coordinated upregulation in 2-cell embryos
(supplementary material Fig. S3). As shown in Fig. 1C, we
compared expression levels among three classes of genes that were
expressed in 2-cell embryos: genes whose corresponding pancRNA
is not transcribed (Group A), and those whose partner is among the
100 most weakly (Group B) or 100 most strongly (Group C)
expressed of the 836 pancRNAs. The average gene expression level
correlated with the presence of the respective pancRNA, and the
expression levels of the Group C genes were significantly higher
than those of Group A and B genes. Moreover, the difference in
pancRNA expression level between MII and 2-cell embryos was
positively correlated with that of the partner mRNA (Fig. 1D).
Interestingly, based on the gene ontology function enrichment
analysis, we found that cell death-related genes were enriched
among co-upregulated pancRNA-partnered genes (supplementary
material Tables S1 and S2). These results support our hypothesis
that zygotic pancRNAs are involved in the upregulation of their
cognate genes.
To test whether particular sequences are potentially involved in
the regulation of pancRNA expression in zygotic pancRNA-
partnered genes, we performed de novo motif searching and found
a CT-rich motif (Fig. 1E; supplementary material Fig. S4A). Since
pancRNA-partnered genes frequently contain a CpG island (CpGi)
within their promoter region (supplementary material Fig. S4B), we
investigated whether CT-rich motifs were enriched within the
CpGi-type promoters. We calculated the CT-rich motif frequency
within the promoters of CpGi-type and non-CpGi-type genes, and
found that the CT-rich motif was present more frequently in the
former (56.1% versus 44.8%; supplementary material Fig. S4C).
These results suggest that the CT-richmotif is associated with CpGi.
Most importantly, the distribution pattern of this CT-rich motif
clearly differed between pancRNA-partnered genes and pancRNA-
lacking genes (Fig. 1F). In pancRNA-partnered genes, the CT-rich
motif was frequently observed on the sense strand of the promoter
and on the antisense strand of the gene body. By contrast, in
pancRNA-lacking genes, the CT-rich motif was observed on the
antisense strand of not only the gene body but also the promoter
(supplementary material Fig. S5). This indicates that the
transcription start sites (TSSs) of the pancRNA-partnered genes
are the switching points for the observed asymmetric distribution of
the CT-rich motif.
Ability of pancRNAs to regulate gene activation
To examine the function of the ZGA-associated pancRNA, we
selected highly expressed pancRNAs that were upregulated at the
2-cell stage and whose expression was maintained at a high level in
ESCs (supplementary material Table S3), and characterized the
three most highly expressed in ESCs, namely those partnered
with Il17d ( pancIl17d), Mospd3 ( pancMospd3) and Tbc1d22a
( pancTbc1d22a) (Fig. 2A). First, we examined their expression
Fig. 2. Effect of pancRNA knockdown on the expression of the counterpart gene during early development. (A) 5′-regions of mouse Il17d, Mospd3
and Tbc1d22a. Vertical lines mark the locations of CpG dinucleotides. Thick horizontal lines denote the regions analyzed by bisulfite sequencing. Primer
positions are numbered relative to the TSS of each gene. (B) qPCR analysis of pancRNA andmRNA at the Il17d,Mospd3 and Tbc1d22a loci in MII oocytes and in
fertilized 1-cell, 2-cell and 4-cell embryos. Error bars indicate s.e.m. (C) DNA methylation levels of the promoter regions of Il17d, Mospd3 and Tbc1d22a in
MII oocytes, sperm and fertilized 1-cell and 2-cell embryos. Filled and open circles indicate methylated and unmethylated cytosines, respectively. *P<0.05;
**P<0.01; ***P<0.001.
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patterns in the MII oocyte, sperm, and fertilized 1-cell and 2-cell
embryo by RT-qPCR (Fig. 2B). We confirmed that all of these
pancRNAs were expressed at the 2-cell stage, and found that the
expression ofMospd3 and Tbc1d22amRNAs was also upregulated
at the 2-cell stage (Fig. 2B, middle and right panels), whereas the
expression of Il17d mRNA was first detected at the 4-cell stage
(Fig. 2B, left panel). Thus, expression of the pancRNA preceded or
occurred simultaneously with that of the mRNA at these loci during
early embryogenesis.
Next, we analyzedwhether the promotermethylation status reflects
the gene activation/repression status. Since core promoter regions,
which frequently show high CpG density, tend to be constitutively
hypomethylated, and the flanking sequences with lower CpG density
tend to be associated with developmental gene regulation (Meissner
et al., 2008), we surveyed such developmentally regulated regions
using publicly available MethylC-seq data of mouse germ cells and
2-cell embryos (Wang et al., 2014) at the three loci (supplementary
material Fig. S6). Bisulfite sequencing indicated that this region in the
Il17d promoter is considerably methylated at the MII oocyte, sperm
and 1-cell stages (Fig. 2C). By contrast, this region became almost
completely demethylated by the 2-cell stage, while the region located
nearer the TSS was constitutively free of methylation, as expected
from the MethylC-seq data (supplementary material Fig. S7).
Similarly, the promoter regions of Mospd3 and Tbc1d22a were
methylated at theMII oocyte, sperm and 1-cell stages, and their DNA
methylation levels decreased by the 2-cell stage. The concordance
between the observed kinetics of expression of the pancRNAs and the
changes in DNA demethylation raised the possibility that these
pancRNAs mediate gene activation through epigenetic changes.
Since we previously found that pancRNAs could activate gene
expression in rat differentiated cell lines (Tomikawa et al., 2011), we
tested whether these developmentally expressed pancRNAs could
be involved in the gene upregulation in early mouse embryos by
knocking them down using siRNAs. We found that microinjection
of siRNA for pancIl17d, pancMospd3 or pancTbc1d22a into the
pronucleus suppressed expression of the partner mRNA at the
2-cell and 4-cell stage, when partner expression normally begins
(Fig. 3A), and this suppression was accompanied by a lack of
decline in the methylation level in the respective promoter region
(Fig. 3B; supplementary material Fig. S8). At the Il17d locus, this
knockdown effect could be rescued by co-injection of the pancIl17d
overexpression vector (Fig. 3B). Overexpressed pancIl17d
might work as a sponge for the siRNA, and these pancRNAs
might mediate acquisition of the hypomethylated status of the
corresponding promoters and potentiate subsequent gene expression
after fertilization.
Fig. 3. Effect of knockdown of pancRNAs on partnered gene expression and on DNA methylation. (A) Expression levels of the indicated pancRNAs
and their genes measured by qPCR in siRNA-injected 2-cell and 4-cell embryos. Il17d expression was not detectable (N.D.) in 2-cell embryos. (B) DNA
methylation levels of the corresponding promoters in siRNA-injected embryos. The regions analyzed are displayed in Fig. 1A. (C) Effect of pancRNA knockdown
on blastocyst formation. Asterisks indicate significant differences compared with si Control samples. The numbers of embryos used for injection of si Control,
si pancIl17d, si pancMospd3 and si pancTbc1d22a siRNAs were 261, 251, 78 and 70, respectively. *P<0.05; **P<0.01; ***P<0.001. Error bars indicate s.e.m.
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Developmental defect caused by pancIl17d knockdown
during preimplantation stages
To investigate the effects of knocking down the above three
pancRNAs on preimplantation development, we monitored the rate
of successful blastocyst formation in the knockdown embryos
(Fig. 3C). 69.6±6.4% of control siRNA-injected, 64.8±4.0% of
pancMospd3 knockdown and 68.6±6.6% of pancTbc1d22a
knockdown embryos successfully developed to the late blastocyst
stage in vitro. By contrast, only 21.5±4.7% of pancIl17d knockdown
embryos reached the late blastocyst stage (Fig. 3C). This
developmental defect was also produced using another siRNA for
pancIl17d (supplementary material Fig. S9). Regarding pancMospd3
knockdown, althoughwe could not see clear effects in the blastocysts,
we found a deficiency of hatching after extending the culture of such
embryos. After 5 days, a significant fraction of the pancMospd3
knockdown embryos did not hatch from the zona pellucida, whereas
most of the control embryos hatched (supplementary material
Fig. S10A,B). Similar results were observed in ESCs: pancMospd3
knockdown resulted in a decreased numberof cells comparedwith the
control ESCs (supplementary material Fig. S10C).
Since the effect of pancIl17d knockdown was drastic, we focused
on investigating the roles of this pancRNA in embryonic
development. Many pancIl17d knockdown embryos died between
the 8-cell and early blastocyst stages. To establish whether cell death
was enhanced in the pancIl17d knockdown embryos, we performed
TdT-mediated dUTP nick-end labeling (TUNEL) staining of the
pancIl17d knockdown embryos at the morula stage (Fig. 4A).
Consistent with a previous report (Brison and Schultz, 1997),
control embryos underwent little apoptosis during blastocyst
formation. By contrast, pancIl17d knockdown embryos exhibited
multiple TUNEL-positive blastomeres, suggesting that many
pancIl17d knockdown embryos died by the blastocyst stage due
to excessive apoptosis. It is noteworthy that the developmental
capacity to form a blastocyst was restored when recombinant mouse
IL17D protein (rIL17D) was added to the medium at the 4-cell
stage, although the knockdown effect continued until the morula
stage (Fig. 4B,C). The addition of rIL17D significantly increased
the rate of success of blastocyst formation in pancIl17d knockdown
embryos (from 21.5±2.7% to 62.1±5.9%; Fig. 4D). These results
suggest that pancIl17d plays an important role in blastocyst
formation by upregulating the partner gene.
In order to assess the role of pancIl17d in preimplantation
embryos, we performed RNA-seq of pancIl17d knockdown morula
embryos and compared the data with those for control siRNA-
injected morula embryos (Fig. 4E). Gene ontology analysis revealed
that apoptosis-related genes were enriched among the upregulated
genes in the knockdown embryos (supplementary material
Table S4). This is in accord with the observation that aberrant
apoptosis is induced by pancIl17d knockdown, as shown in
Fig. 4A. Interestingly, embryonic development-related genes were
enriched among the downregulated genes. The second and third
most highly expressed genes among the downregulated genes were
Nanog and Cdx2, respectively, which encode transcription factors
important for maintaining pluripotency and for the specification
of cell lineages to generate trophectoderm, respectively (Chambers
et al., 2003; Strumpf et al., 2005) (supplementary material
Fig. S11). For example, the importance of pancRNAs for
trophectoderm cell generation was supported by immunostaining
of CDX2 of pancIl17d knockdown blastocysts, which showed that
some outer blastomeres of pancIl17d knockdown embryos lost
CDX2 expression (Fig. 4F). Therefore, pancIl17d seems important
for the capacity to differentiate to generate trophectoderm cells.
Impairment of in vitro colony formation from pancIl17d
knockdown embryos
To further investigate the significance of pancIl17d for embryonic
development, we plated the surviving pancIl17d knockdown
blastocysts in medium containing mouse LIF and inhibitors for
MEK1/2 (MAP2K1/2) and GSK3β (2i medium), conditions that
are frequently utilized for the culture of ground-state ESCs, and
harvested the cultures after 10 days. Whereas about 70% of the
control siRNA-injected embryos produced ESC-like colonies on
average, only 10-20% of the pancIl17d knockdown embryos did
so (Fig. 5A). Even when pancIl17d knockdown embryos did
produce colonies, they were significantly smaller than those
derived from control siRNA-injected embryos (Fig. 5B,C),
indicating that pancIl17d knockdown decreases the ability to
form a colony. These knockdown-induced impairments were also
rescued by the addition of rIL17D to the culture medium at the
4-cell stage, strongly suggesting that the effects of pancIl17d
knockdown are mediated by the downregulation of Il17d gene
expression.
We further investigated the effect of pancIl17d knockdown in
ESCs. siRNA-induced pancIl17d knockdown resulted in a decrease
in the number of ESCs compared with the control siRNA (Fig. 5D).
When pancIl17d was knocked down in ESCs, TUNEL-positive
cells were significantly increased compared with the control
(Fig. 5E). These results indicated that the loss of pancIl17d led to
apoptotic cell death also in ESCs. In parallel, we analyzed the
proliferative ability of the pancIl17d knockdown ESCs by
performing a 5-ethyl-2′-deoxyuridine (EdU) incorporation
experiment. The number of EdU-positive cells was significantly
decreased in the pancIl17d knockdown cells compared with the
control cells (Fig. 5F). These inhibitory effects of pancRNA
knockdown on the proliferation of ESCs were reproduced by
mRNA knockdown (Fig. 5D-F). Taken together, these results
indicate that the pancIl17d-Il17d pair forms a molecular axis that is
necessary for both cell survival and proliferation.
We analyzed the expression of pluripotency marker genes,
includingOct3/4 (Pou5f1), by RT-qPCR. Knockdown of pancIl17d
or of Il17d mRNA caused significant decreases in the expression
levels of Oct3/4, Klf4, c-Myc and Cdh1, but not of Sox2 (Fig. 5G).
We also performed the embryoid body (EB) formation assay using
shRNA-transfected ESCs (supplementary material Fig. S12). EB
size was altered by transfection of shRNA for pancIl17d,
accompanied by increased expression levels of Otx1 and Gata6,
which are marker genes for the ectodermal and endodermal
lineages, respectively. This indicated that pancIl17d knockdown
causes abnormal EB formation.
Identification of the pathway triggering pancRNA-mediated
gene upregulation
A previous study showed that base excision repair (BER)
components, including poly(ADP-ribose) polymerase (PARP),
contribute to DNA demethylation in preimplantation embryos
(Hajkova et al., 2010). Therefore, we added a PARP inhibitor,
3-aminobenzamide (ABA), to the embryo culture medium to clarify
whether promoter demethylation requires the BER pathway. The
addition of ABA resulted in inhibition of DNA demethylation of the
Il17d promoter region at the 2-cell stage (Fig. 6A; supplementary
material Fig. S13), leading to downregulation of the partner mRNA
(supplementary material Fig. S14). However, the addition of ABA
did not change pancRNA expression, suggesting that expression of
pancIl17d itself is regulated independently of the BER pathway and
DNA methylation.
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Considering recent reports showing that ten-eleven translocation
(TET) enzymes are among the key molecules triggering BER
pathways (Kohli and Zhang, 2013; Teperek-Tkacz et al., 2011), we
knocked down Tet3, which is abundantly expressed in early
embryos, and Tet2, which shows lower expression than Tet3 in
preimplantation embryos (supplementary material Table S5). Tet3
knockdown embryos showed significantly higher DNAmethylation
levels than control embryos. By contrast, knockdown of Tet2 did not
induce significant DNA methylation changes (Fig. 6B), suggesting
that Tet3, but not Tet2, is required for DNA demethylation at the
Il17d promoter. Fig. 6C summarizes pancRNA-mediated sequence-
specific gene upregulation.
DISCUSSION
The key molecules that enable sequence-specific gene activation to
initiate embryonic development remain largely unknown. Here, we
identified more than 1000 pancRNAs as candidates of such key
molecules in early mouse embryos. To examine the function of the
ZGA-associated pancRNA, we focused on three abundant
pancRNAs: pancIl17d, pancMospd3 and pancTbc1d22a. We
found that these three pancRNAs had the ability to reprogram the
epigenetic status of promoter regions for gene activation in a
sequence-specific manner. We also proved that pancIl17d plays an
essential role in early embryogenesis. Our study thus sheds light on
novel mechanisms by which a fraction of zygotically activated
Fig. 4. Developmental defects induced by pancIl17d knockdown and rescue by addition of recombinant IL17D protein. (A) TUNEL assay of morula
embryos. Arrowheads indicate TUNEL-positive blastomeres. pancIl17d knockdown embryos showed increased TUNEL-positive cells. Two representative
blastomeres are shown. To the right is a box plot of the number of TUNEL-positive cells in each embryo. (B) Morphology of late blastocysts. (C) Expression levels
of pancIl17d and Il17dmeasured by qPCR in control, pancIl17d knockdown and rIL17D-supplemented pancIl17d knockdown morula embryos. (D) Survival rate
of control and pancIl17d knockdown embryos at day 4.5 of in vitro culture. Two different siRNAs targeting pancIl17d were used. (E) Scatter plots of gene
expression in control and pancIl17d knockdown morula embryos based on the RPKMs of RefSeq genes. Red dots indicate the genes that show statistically
significant changes. (F) Immunostaining of CDX2 protein in control and pancIl17d knockdown late blastocyst. Arrowheads indicate CDX2-negative outer cells
Beneath is a box plot of the number of CDX2-negative outer cells in each embryo *P<0.05; ***P<0.001. Error bars indicate s.e.m.
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lncRNAs enhance partner gene promoter activity for subsequent
mouse embryogenesis.
The effects of pancRNAs on gene regulation in many
biological processes
In this study, the RNA-seq method was adapted for small-scale
samples to yield RNA-seq data at a level comparable to that
generated from large-scale samples (supplementary material
Fig. S2). Indeed, pancRNAs were detected from more than 1000
promoter regions during ZGA (Fig. 1A). This is consistent with
previous reports showing that thousands of pancRNAs are
transcribed in terminally differentiated mouse tissues and ESCs
(Sigova et al., 2013; Uesaka et al., 2014). Thus, a substantial
number of pancRNAs seems to be expressed in various cell
contexts, including totipotent stages, as we show here. Since
pancRNAs and mRNAs exhibit coordinated expression changes not
only in somatic cells but also in preimplantation embryos (Fig. 1D),
pancRNAsmight be commonly utilized for gene activation from the
zygotic to the terminally differentiated stages. According to their
partner genes, pancRNAs function in the regulation of many
biological processes, a conclusion supported by our pancIl17d
knockdown experiments.
Fig. 5. Effect of pancIl17d knockdown on colony outgrowth from blastocysts and on ESC properties. (A) Rate of colony outgrowth from knockdown and
rescued blastocysts. Colonies growing after 10 days in culture were counted. (B) Representative images of colonies derived from siRNA-injected embryos.
(C) Box plot of diameter of colonies derived from pancRNA knockdown blastocysts. (D) Number of ESCs 24 h after siRNA introduction by electroporation.
(E) Proportion of apoptotic cells detected by TUNEL staining in knocked down ESCs after siRNA introduction. (F) Proportion of proliferating ESCs, as analyzed
by EdU labeling. (G) Expression levels of pancIl17d, Il17d and pluripotency marker genes in ESCs, as detected by RT-qPCR. Gapdh was used as a control.
The expression level in control-transfected ESCs was set as 1. Asterisks indicate significant differences compared with si Control samples. *P<0.05; **P<0.01;
***P<0.001. Error bars indicate s.e.m.
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Sequence-specific transcriptional activation mediated by
pancRNAs
There have been several reports on the molecular basis of
lncRNA-mediated transcriptional regulation in trans [for a review
see Fatica and Bozzoni (2014)]. For example, HOTAIR represents a
set of lncRNAs that can influence dispersed genomic regions
(Chu et al., 2011). By contrast, we now think that a single pancRNA
acts to mediate corresponding gene activation in cis: knockdown
of pancIl17d, pancMospd3 or pancTbc1d22a resulted in
downregulation of the partner gene, and this downregulation was
accompanied by a hypermethylated status of the corresponding
promoter regions (Fig. 3A,B). In addition, we found that pancIl17d
expression preceded Il17d expression (Fig. 2B; supplementary
material Fig. S15), also supporting the notion that the pancRNA
epigenetically activates its partner gene in cis. However, we cannot
completely exclude the possibility that a pancRNA affects
expression of other genes in trans. Nonetheless, we believe that
the trans effect, if any, on preimplantation development was
relatively small, because several developmental defects caused by
knocking down pancIl17d were rescued by addition of rIL17D
protein. These findings strongly support the idea that a pancRNA
specifically regulates expression of the gene with which it shares a
bidirectional promoter region.
The mechanism of pancRNA-triggered gene activation
One possible scenario is that gene activation-associated pancRNAs
specify the genomic position for establishing an epigenetic status
that is conducive to gene activation with TET3 and BER
components (Fig. 6A,B), which are involved in genome-wide
DNA demethylation (Branco et al., 2012; Hajkova et al., 2010).
However, we do not yet know what factors initiate the expression of
gene activation-associated pancRNAs. In this study, we tried to
identify such factors and found strand-specific enrichment of a
CT-rich motif in a set of zygotic pancRNA-partnered genes
(Fig. 1F). The TSSs of the pancRNA-partnered genes provide the
switching points for the observed asymmetric distribution of the
CT-rich motif (supplementary material Fig. S5). Considering the
divergent transcription of mRNA and pancRNA, the distribution
pattern of this CT-rich motif seems to be preferentially located
upstream of both pancRNAs and mRNAs. This raises the possibility
that the coordinated expression of pancRNAs and mRNAs is
regulated by similar machineries. This hypothesis is supported by
the fact that the expression of 426 out of 568 pancRNAs increased at
the 2-cell stage concomitantly with the increase in corresponding
mRNA expression (supplementary material Fig. S3). However, the
factor that binds to this CT-rich motif remains to be identified;
indeed, the CT-rich motif is present upstream of pancIl17d and
pancTbc1d22a, but not pancMospd3, and therefore information on
additional sequence motifs and their binding factors will be needed
to clarify the driving force that reprograms the chromatin structure in
conjunction with pancRNA activation.
Although the pancRNA expression change seems to coincide
with the DNA methylation change during preimplantation
development, the effect on DNA methylation might be exerted
indirectly. For example, DNAmethylation and histone modification
work together in gene silencing, and pancRNAs might initially
affect some epigenetic/transcriptional environmental condition,
such as histone modification status, leading to the DNA
demethylation. Further advances in histone modification analysis
techniques will enable us to dissect the exact kinetics of epigenetic
changes triggered by pancRNA expression and thus aide in the
identification of the molecular complex(es) that functions with
pancRNA for sequence-specific gene activation.
Developmental roles of pancRNAs
It is clear that the pancIl17d-Il17d pair performs some functions at
the preimplantation stage. We speculate that some of the other
upregulated pancRNA/gene pairs affect embryonic development.
Several lncRNAs have also been shown to be involved in mouse
postimplantation development [for a review see Fatica and Bozzoni
(2014)]. For example, knockout mice of the lncRNA Fendrr, which
is derived from the promoter region of Foxf1, die around embryonic
day 14 due to impairment of heart development. Although
knockdown of pancMospd3 did not cause any detectable
developmental defects in blastocyst formation (Fig. 3C), it must
function thereafter, since mice lacking the Mospd3 gene display
neonatal lethality with defects of heart development (Pall et al.,
2004). This notion is supported by our data showing that
pancMospd3 knockdown caused failure of hatching from the zona
pellucida (supplementary material Fig. S10).
Interestingly, cell death-related genes were enriched among co-
upregulated pancRNA-partnered genes (supplementary material
Tables S1 and S2). These include Bag6, Pdcd2,Map3k7 and Fadd,
Fig. 6. Epigenetic changes accompanying zygotic pancRNA-mediated
gene activation during early mouse development. (A) DNA methylation
status of ABA-treated 2-cell embryos. (B) DNA methylation status of Tet2 or
Tet3 versus control siRNA-injected embryos. ***P<0.001. (C) A model for
pancRNA-mediated gene activation in early mouse development. At the
2-cell stage, pancIl17d expression, together with TET3 and PARP, leads to
establishment of the hypomethylated status at the Il17d promoter in a
sequence-specific manner, and thus to Il17d mRNA expression starting
from the 4-cell stage. When these steps are compromised, apoptosis
increases and cell proliferation decreases, adversely affecting embryonic
development.
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which are essential for embryonic development (Fabian et al., 2005;
Jadrich et al., 2006; Mu et al., 2010; Yeh et al., 1998). For example,
Bag6 knockout mice die with defects of kidney, lung and brain
formation as a result of dysregulation of apoptosis and cell
proliferation (Fabian et al., 2005). In accord with this, our
pancBag6 knockdown experiment showed increased cell death
among ESCs (supplementary material Fig. S16). Therefore,
pancRNAs seem to be produced at a significant number of gene
promoters that should be regulated according to the developmental
context.
This raises the intriguing question of why pancRNAs are
employed within the developmental gene regulation network. One
possibility is that pancRNAs have been adopted to increase the
complexity of the regulatory network system. The novel layer of
transcriptional regulation imposed by the acquisition of pancRNAs
might have contributed to generating numerous varieties of gene
expression patterns during development (Imamura et al., 2014).
Recently, it has been reported that lncRNAs, including pancRNAs,
are frequently regulated by developmentally important factors, such
as homeobox proteins, (Necsulea et al., 2014), supporting our idea
that pancRNAs acts together with other regulatory factors for
complex and orchestrated developmental gene regulation.
The knockdown of pancTbc1d22a and pancBag6 did not cause
marked defects in preimplantation development. As described
above, pancRNAs function in the regulation of many biological
processes according to their partner genes. In fact, Tbc1d22a
belongs to the TBCK gene family, whose members are thought to
act as GTPase-activating proteins and to influence cell proliferation
through mTOR signaling (Alexander et al., 2013; Liu et al., 2013).
Thus, although Tbc1d22a might have a role during development, it
is possible that paralogs of Tbc1d22a might compensate for the
knockdown effect. The same might be true for pancBag6, the
knockdown of which resulted in only a slight decrease in ESC
number (supplementary material Fig. S16).
Conclusion
We conclude that gene activation-associated pancRNA provides a
new layer of epigenetic regulation during mammalian development.
MATERIALS AND METHODS
Preparation of oocytes, embryos, sperm and ESCs
MII oocytes were obtained from the oviducts of 7- to 8-week-old F1
mice (C57BL/6×C3H) induced to superovulate by intraperitoneal
injection of 5 IU of pregnant mare serum gonadotropin (Asuka),
followed 48 h later by injection of 5 IU of human chorionic
gonadotropin (hCG, Asuka). Embryos were obtained after mating the
superovulated females with F1 males. Oocytes and zygotes were
recovered in M2 medium (Sigma) 17 h after hCG injection, and then,
following removal of cumulus cells with 0.03% hyaluronidase (Sigma),
they were either subjected to direct methylation analysis and RNA
analysis, or cultured in M16 medium (Sigma) at 37°C under 5% CO2/air
for the collection of fertilized embryos. Sperm were obtained from F1
male epididymis, and motile sperm of good quality were selected by the
direct swim-up method (Younglai et al., 2001). The embryos were
treated with ABA (Sigma) as previously described (Imamura et al.,
2004a). Blastocysts were plated in N2 medium containing B27
(Invitrogen), 2-mercaptoethanol (Wako), GlutaMAX-I (Gibco), bovine
serum albumin fraction V (Sigma), LIF (Millipore), PD0325901 (Sigma)
and CHIR99021 (Axon) (2i medium) (Ying et al., 2008) and cultured for
10 days. ESC-like colonies were processed for immunohistochemistry.
ESCs were cultured on a 0.1% gelatin-coated dish in a 37°C incubator
under 5% CO2/air, and propagated by trypsinizing and replating every 2
or 3 days. EB formation and in vitro hatching are described in the
supplementary methods.
Directional RNA-seq library preparation
Total RNA and poly(A)+ RNA were extracted from pools, each of which
contained 100 MII oocytes, 2-cell embryos (C57/B6×ICR), control siRNA-
injected morula embryos or pancIl17d knockdown morula embryos, using
the Dynabeads mRNA DIRECT Micro Kit (Invitrogen). Four replicates
were made for directional RNA-seq library construction using the NEBNext
Ultra Directional RNA Library Prep Kit for Illumina (NEB). In this library
preparation, cDNAs were enriched by 15-cycle PCR. Illumina HiSeq 2000
was used to perform 50 bp single-end sequencing according to the
manufacturer’s instructions. RNA-seq data have been deposited in theDDBJ
Sequence Read Archive (DRA) under accession number DRA002400.
Data mining
Sequencing reads obtained from our directional RNA-seq (DRA:
DRA002400) and publicly available data [NCBI Sequence Read Archive
(SRA)] for ESCs (SRA:SRR315596) were assessed with the FASTX tool
kit (Patel and Jain, 2012) to remove short (<20 bp) and low quality (quality
score <20) reads, followed by trimming of the adaptor sequence.
Preprocessed reads were mapped to the mouse mm10 genome using
TopHat2/Bowtie2 (Kim et al., 2013). Cufflinks and Cuffdiff (Trapnell et al.,
2012) were used for the reads per kb of exon model per million mapped reads
(RPKM) calculation and differential expression analyses. For pancRNA
quantification, we counted only reads that mapped to the antisense sequences
of the promoter regions (−1000 to −1 bp from the TSS) of genes, because
pancRNAs corresponding to antisense sequences of the promoter regions
show the potential to increase mRNA production (Tomikawa et al., 2011;
Uesaka et al., 2014). If a promoter region overlapped with another RefSeq
gene, the promoter was excluded from the dataset to avoid contamination of
the pancRNA pool by protein-coding genes. Hierarchical clustering of
sequenced samples based on gene expression levels was drawn using the
cummeRbund package (http://rgm3.lab.nig.ac.jp/RGM/R_package_list). For
motif searches within the promoter sequences, ≥10-fold upregulated
pancRNAs in 2-cell embryos were selected by comparing their levels with
those in MII oocytes. The −200 to −1 bp sequences (relative to the TSS) of
370 corresponding mRNAs were examined using rGADEM, one of the
Bioconductor packages (Gentleman et al., 2004). To verify the presence of a
motif in the pancRNA-partnered gene loci, we further extracted and counted
genes that possessed or lacked sequences showing 90% ormore identity to the
candidate motif using the matchPWM program in the Biostrings package
(Pages et al., 2013). pancRNA-mRNA sets subjected to the experiments
described below were selected based on the following criteria: RPKM <0.5
in MII oocytes, RPKM >1 in 2-cell embryos and ESCs (supplementary
material Table S3).
PCR detection of pancRNA and mRNA
To quantify the pancRNA and mRNA expression levels in the embryos, we
purified total RNAs from sperm, oocytes, and fertilized 1-cell
(corresponding to 30 h after hCG injection), 2-cell (44 h) and 4-cell (54 h)
embryos using the Dynabeads mRNA DIRECT Micro Kit and subjected
them to reverse transcription. For ESCs, 3 µg total RNA that had been
extracted using TRIzol (Invitrogen) was utilized for reverse transcription
with SuperScript III (Invitrogen) reverse transcriptase. The synthesized
cDNAs were subjected to qPCR using the KAPA SYBR Fast qPCR Kit
(KAPA Biosystems). The primers used in these analyses are listed in
supplementary material Table S6. Gapdh was used as an internal control.
Bisulfite sequencing
To determine the DNA methylation profiles of the Il17d, Mospd3 and
Tbc1d22a promoter regions, sample pools consisting of genomic DNA from
20-50 oocytes or embryos were subjected to the bisulfite reaction using the
MethylCode Kit (Invitrogen) according to the manufacturer’s instructions.
Each bisulfite-treated genome was amplified using AmpliTaq Gold 360
Master Mix (Life Technologies) or EpiTaq HS (TaKaRa) and the specific
primers listed in supplementarymaterial Table S6. In order to avoid PCR bias,
we subcloned more than five PCR bands as previously described (Imamura
et al., 2005), and performed bisulfite sequencing of more than 20 of the
resulting subclones, for each sample. Visualization of MethylC-seq data is
described in the supplementary methods.
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pancRNA knockdown and overexpression experiments
We microinjected 5-10 pl of 2 µM siRNA that targeted pancRNA of Il17d,
Mospd3 or Tbc1d22a (supplementary material Table S7), together with
5 ng/μl N2-EGFP vector (Clontech), into the pronuclei of fertilized embryos
21 h after hCG injection. In a rescue experiment of siRNA knockdown,
5 ng/μl pancIl17d overexpression construct [−706 bp to −418 bp relative
to the TSS of Il17d in pRC/CMV (Invitrogen)] was simultaneously
microinjected into the pronuclei. In the case of siRNAs that targeted Tet2
and Tet3 mRNAs, 5-10 pl of each siRNA at 50 µM was injected into the
cytoplasm of embryos 14 h after hCG injection. As a negative control for
siRNA experiments, we used the MISSION siRNA universal negative
control (Sigma). siRNA-injected embryos were used for DNA methylation
and RNA analyses. To look for possible morphological changes, in vitro
culture was continued for 3 more days. In some cases, recombinant IL17D
(R&D Systems) was added to a final concentration of 100 ng/ml at the 4-cell
stage.
For knockdown experiments, ESCs were transfected with each siRNA
(100 nM final concentration) as listed in supplementary material Table S7,
together with pEGFP-N2 vector (Clontech), by electroporation with the
Neon Transfection System (Invitrogen). At 24 h after transfection, cells
were used for TUNEL assay, EdU labeling assay or RT-qPCR. For longer
duration knockdown experiments in ESCs, pLLX-shRNA expression
vectors, which were generously provided by Drs Z. Zhou and M. E.
Greenberg (Lois et al., 2002; Zhou et al., 2006) and were modified to
express GFP together with a puromycin resistance gene under the ubiquitin
C promoter, were prepared as listed in supplementary material Table S7.
Human embryonic kidney cells were used as producers of lentiviruses that
contained the modified pLLX-shRNA expression vectors. After 2 days of
infection, ESCs were selected with puromycin for 3 days to check their
phenotypes.
Cell staining
Immunohistochemistry was performed as follows: fixation with 4% PFA
for 20 min at room temperature; washing twice in PBS; permeabilization
and blocking in blocking buffer (0.1% Triton X-100 and 3% FBS in PBS)
for 1 h at room temperature; overnight incubation with primary antibodies
diluted 1/500 in blocking solution; washing three times in PBS; incubation
with Hoechst 33258 (Nacalai Tesque) and secondary antibody diluted 1/
500 in blocking solution for 1 h in the dark at room temperature; and
washing three times in PBS. Imaging was performed with a Leica AF6000
microscope. The primary antibody mouse anti-CDX2 (MU392A-UC,
BioGenex) was used for immunostaining. CF488A donkey anti-mouse
IgG (Biotium) secondary antibody was used to visualize signals. For the
TUNEL assay, cells were stained with TMR Red using the In Situ Cell
Death Detection Kit (Roche) according to the manufacturer’s instructions.
For the EdU assay, EdU of the Click-iT EdU Imaging Kit (Invitrogen) was
added to the ESC culture medium by exchanging half the medium and
culturing for 4 h; the cells were then fixed with 4% PFA, permeabilized
with 0.1% Triton X-100 in PBS, and stained with 1× Click-iT Reaction
Buffer and Hoechst 33258.
Statistical analysis
All data are reported as the mean±s.e.m. Student’s t-test was used for
comparisons between two groups. Unless there is a specific statement about
the number of replicates, three replicates were analyzed for each experiment.
Tukey’s multiple comparison test was used for comparisons among three or
more groups. The Mann–Whitney U-test was used to compare DNA
methylation levels among samples.
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